Ex-post evaluation, EU competition enforcement and acquisitions of innovative competitors in the pharma sector leading to the discontinuation of overlapping drug research and development projects (2024)
Abstract
No abstract provided
Bibliographic Information
Publication URI: https://op.europa.eu/publication-detail/-/publication/6eacab93-b129-11ef-acb1-01aa75ed71a1
Type: Technical Report
ISBN: 978-92-68-22468-7